Metabolon, Inc. North Carolina

Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform

and Twitter.

About Reactome
Reactome is an open-source, open-access, manually curated, and peer-reviewed pathway database.  Our goal is to provide intuitive bioinformatics tools for the visualization, interpretation, and analysis of pathway knowledge to support basic and clinical research, genome analysis, modeling, systems biology, and education.  Founded in 2003, the Reactome project is led by Lincoln Stein of OICR, Peter D'Eustachio of NYU Langone Health, Henning Hermjakob of EMBL-EBI, and Guanming Wu of OHSU.  The Reactome database and website enable scientists, researchers, students, and educators to find, organize, and utilize biological information to support data visualization, integration, and analysis.

About Metabolomics
Metabolomics, the large-scale study of all small molecules in a biological system, is the only omics technology that provides a complete current-state functional readout of a biological system.  Metabolomics helps researchers see beyond the genetic variation of individuals, capturing the combined impact of genetic and external factors such as the effect of drugs, diet, lifestyle, and the microbiome on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug's mechanism of action, pharmacodynamics, and safety profile, as well as individual responses to therapy.

Logo - https://mma.prnewswire.com/media/1671125/Metabolon_Inc_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/metabolon-unveils-new-multiomics-biomarker-discovery-functionality-via-its-industry-leading-integrated-bioinformatics-platform-302387182.html